CBD and Green Tea Compound Together Block SARS-CoV-2 at Multiple Levels
CBD and EGCG (from green tea) showed complementary antiviral effects against SARS-CoV-2 — CBD reduced ACE2 expression while EGCG suppressed spike protein, together blocking virus at multiple stages.
Quick Facts
What This Study Found
CBD decreased ACE2 receptor expression (virus entry point), while EGCG suppressed spike protein expression. Combined, they complement each other to inhibit SARS-CoV-2 at multiple levels — entry, protein expression, and reinvasion — while minimizing adverse effects of ACE2 changes.
Key Numbers
CBD and tea polyphenols showed inhibitory effects comparable to chloroquine (positive control). EGCG identified 11 spike protein-interacting proteins significantly affected. Transcriptome analysis showed overlapping and distinct gene regulation pathways.
How They Did This
In vitro study testing CBD, green tea polyphenols, EGCG, and theaflavin against SARS-CoV-2, using co-immunoprecipitation mass spectrometry, transcriptome analysis, and functional pathway enrichment.
Why This Research Matters
Finding natural compounds that work together against coronaviruses through complementary mechanisms provides a framework for developing combination antiviral strategies using safe, accessible compounds.
The Bigger Picture
The COVID-19 pandemic highlighted the need for diverse antiviral strategies. Natural compounds like CBD and EGCG offer multi-target mechanisms that may be harder for viruses to develop resistance against compared to single-target drugs.
What This Study Doesn't Tell Us
In vitro study only — tissue concentrations achievable in humans may be insufficient. COVID-19 landscape has evolved significantly since study conception. Viral variants may respond differently.
Questions This Raises
- ?Could CBD/EGCG combinations be effective as prophylactic supplements?
- ?Would these compounds show activity against other coronaviruses or respiratory viruses?
Trust & Context
- Key Stat:
- Evidence Grade:
- Thorough in vitro investigation with transcriptomic analysis, but lacks animal model validation and clinical relevance remains uncertain.
- Study Age:
- Recent study exploring natural compound combinations against SARS-CoV-2, contributing to ongoing antiviral research.
- Original Title:
- Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.
- Published In:
- Virology, 610, 110579 (2025)
- Authors:
- Zhang, Meng-Chun, Wu, Hao, Wang, Jiaxing, Lu, Meixi, Cao, Danli, Lin, Jingwen, Chen, Hang, Lin, Caiji, Wang, Yao, Zhang, Xing-Hua, Xu, Mengzhi, Liu, Gui-Rong, Li, Han, Wang, Pengfei, Wang, Xiaoyu, Xu, Xiaohui, Liu, Shu-Lin, Liu, Huidi
- Database ID:
- RTHC-08034
Evidence Hierarchy
Frequently Asked Questions
Can CBD prevent COVID-19?
This lab study shows CBD has antiviral effects against SARS-CoV-2 in cell culture, but there's no evidence that taking CBD products prevents or treats COVID-19 in humans.
Why combine CBD with green tea compounds?
They work through different mechanisms — CBD reduces the ACE2 receptor that the virus uses to enter cells, while EGCG suppresses the virus's spike protein. Together, they block the virus at multiple stages.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08034APA
Zhang, Meng-Chun; Wu, Hao; Wang, Jiaxing; Lu, Meixi; Cao, Danli; Lin, Jingwen; Chen, Hang; Lin, Caiji; Wang, Yao; Zhang, Xing-Hua; Xu, Mengzhi; Liu, Gui-Rong; Li, Han; Wang, Pengfei; Wang, Xiaoyu; Xu, Xiaohui; Liu, Shu-Lin; Liu, Huidi. (2025). Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.. Virology, 610, 110579. https://doi.org/10.1016/j.virol.2025.110579
MLA
Zhang, Meng-Chun, et al. "Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.." Virology, 2025. https://doi.org/10.1016/j.virol.2025.110579
RethinkTHC
RethinkTHC Research Database. "Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol..." RTHC-08034. Retrieved from https://rethinkthc.com/research/zhang-2025-multilevel-inhibition-of-sarscov2
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.